Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Sonja Fernbach, Nina K. Mair, Irène A. Abela, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 9
Open Access | Times Cited: 11
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
Adrian Gervais, Astrid Marchal, Andrea Fořtová, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 10
Open Access | Times Cited: 9
IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant
Blanca García‐Solis, María Tapia-Torres, Ana García-Soidán, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 3, pp. 819-826
Open Access | Times Cited: 5
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Jérémie Rosain, Tom Le Voyer, Xian Liu, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 5
Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients
Mario Framil, Lydia García-Serrano, Francisco Morandeira, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design
Kevin Groen, Roger Kuratli, Jannik Enkelmann, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Open Access
Powassan and other emerging neuroinvasive arboviruses in North America
Reece Hass, Michel B. Tolédano
Current Opinion in Infectious Diseases (2025)
Closed Access
Sterile production of interferons in the thymus
Ryan J. Martinez, Kristin A. Hogquist
The Journal of Immunology (2025)
Closed Access
Anti-cytokine autoantibodies in human susceptibility to infectious diseases: insights from Inborn errors of immunity
Kosuke Noma, Takaki Asano, Maki Taniguchi, et al.
Immunological Medicine (2025), pp. 1-17
Open Access
Rapid Detection of Anti‐IFN‐α2 Autoantibodies Using a New Automated VIDAS Assay Prototype
Sylvie Pons, Laurence Generenaz, Adrian Gervais, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 4
Open Access
Identifying genetic errors of immunity due to mosaicism
Elizabeth G. Schmitz, Malachi Griffith, Obi L. Griffith, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 5
Closed Access
Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai
Dongling Shi, Jie Chen, Meng Zhao, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 3
Open Access | Times Cited: 3
Inherited human RelB deficiency impairs innate and adaptive immunity to infection
Tom Le Voyer, Majistor Raj Luxman Maglorius Renkilaraj, Kunihiko Moriya, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 3
CNS disease associated with enhanced type I interferon signalling
Yanick J. Crow
The Lancet Neurology (2024) Vol. 23, Iss. 11, pp. 1158-1168
Closed Access | Times Cited: 3
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
Adrian Gervais, Paul Bastard, Lucy Bizien, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 12
Open Access | Times Cited: 3
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFN non-response
Douglas Fink, David Etoori, Robert Hill, et al.
JHEP Reports (2025) Vol. 7, Iss. 5, pp. 101382-101382
Open Access
SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome
Bruno Pereira de Melo, João M. Silva, Mariana Alves Rodrigues, et al.
Viruses (2025) Vol. 17, Iss. 5, pp. 617-617
Open Access
Longitudinal Analysis Over Decades Reveals the Development and Immune Implications of Type I Interferon Autoantibodies in an Aging Population
Sonja Fernbach, Nina K. Mair, Irène A. Abela, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period
Hyunkyung Cha, Chan Mi Lee, Su‐jin Kim, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
A sensitive assay for measuring whole-blood responses to type I IFNs
Adrian Gervais, Corentin Le Floc’h, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access | Times Cited: 2
Review 2: "Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19"
Marvin J. Fritzler
(2024)
Open Access
Innate immune signatures in the nasopharynx after SARS-CoV-2 Infection and links with the clinical outcome of COVID-19 in Omicron-dominant period
Hyunkyung Cha, Chan Mi Lee, Su‐jin Kim, et al.
Research Square (Research Square) (2024)
Closed Access
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children
Halima Kholaiq, Yousra Abdelmoumen, Abderrahmane Moundir, et al.
Clinical & Experimental Immunology (2024)
Closed Access
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity
Leda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Clinical Immunology (2024) Vol. 267, pp. 110339-110339
Open Access
Finding NEMO in the thymus
Juan Moisés Ocampo‐Godínez, Alexandra Y. Kreins
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access
Page 1 - Next Page

Scroll to top